HL7 Terminology (THO), published by HL7 International - Vocabulary Work Group. This guide is not an authorized publication; it is the continuous build for version 5.5.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/UTG/ and changes regularly. See the Directory of published versions

• Narrative Content
• XML
• JSON
• TTL
• History

CodeSystem: Health Canada Drug Id Number

Official URL: http://hl7.org/fhir/NamingSystem/ca-hc-din				Version: 4.0.1
Active as of 2021-10-04			Responsible: Health Canada	Computable Name: HcDIN
Other Identifiers: urn:ietf:rfc:3986#Uniform Resource Identifier (URI)#urn:oid:2.16.840.1.113883.5.1105

A Drug Identification Number (DIN) is a computer-generated eight digit number assigned by Health Canada to a drug product prior to being marketed in Canada. It uniquely identifies all drug products sold in a dosage form in Canada and is located on the label of prescription and over-the-counter drug products that have been evaluated and authorized for sale in Canada. A DIN uniquely identifies the following product characteristics:

• manufacturer
• product name
• active ingredient(s)
• strength(s) of active ingredient(s)
• pharmaceutical form, and
• route of administration.

Note: The number has a leading zero.

Further information about this Code System can be found at https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/regulatory-requirements-drug-identification-numbers/document.html

This Code system is referenced in the content logical definition of the following value sets:

• This CodeSystem is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)